Moleculin Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. 

CEO
Walter V. Klemp
CEOWalter V. Klemp
Employees
17
Employees17
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2015
Founded2015
Employees
17
Employees17

MBRX Key Statistics

Market cap
17.22M
Market cap17.22M
Price-Earnings ratio
-0.12
Price-Earnings ratio-0.12
Dividend yield
—
Dividend yield—
Average volume
1.20M
Average volume1.20M
High today
$0.60
High today$0.60
Low today
$0.5565
Low today$0.5565
Open price
$0.5967
Open price$0.5967
Volume
1.97M
Volume1.97M
52 Week high
$3.65
52 Week high$3.65
52 Week low
$0.25
52 Week low$0.25

People also own

Based on the portfolios of people who own MBRX. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
Plug Power
NIO
Ocugen, Inc
Tonix Pharmaceuticals
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.